Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract

Cancer Causes and Control

Volumn 18, Issue 4, 2007, Pages 449-455

  Campa, Daniele ^a,b   Hashibe, Mia ^a   Zaridze, David ^c   Szeszenia Dabrowska, Neonila ^d   Mates, Ioan Nicolae ^e   Janout, Vladimir ^f   Holcatova, Ivana ^g   Fabiánová, Eleonóra ^h   Gaborieau, Valérie ^a   Hung, Rayjean J ^a   Boffetta, Paolo ^a   Brennan, Paul ^a   Canzian, Federico ^a,i  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF PISA   (Italy)

^c Chemotherapy Department   (Russian Federation)

^d NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^e CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f PALACKÝ UNIVERSITY   (Czech Republic)

^g CHARLES UNIVERSITY   (Czech Republic)

^h Specialized State Health Institute   (Slovakia)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cyclooxygenase 2; Esophageal cancer; Interleukin 1; Interleukin 8; Larynx cancer; Oral cancer; Pharynx cancer; Upper aerodigestive tract cancers

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 8;

ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; INFLAMMATION; LARYNX CANCER; MAJOR CLINICAL STUDY; PHARYNX CANCER; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

EID: 33947223773     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-007-0129-8     Document Type: Article

References (33)

1. Ferlay J, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, Version 2.0. IARC Cancer Base No. 5, IARC Press, Lyon, France
2. Bray I, Brennan P, Boffetta P (2000) Projections of alcohol- and tobacco-related cancer mortality in Central Europe. Int J Cancer 87(1):122-128
3. International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 83:1-1438
4. Sturgis EM, Wei Q (2002) Genetic susceptibility-molecular epidemiology of head and neck cancer. Curr Opin Oncol 14(3):310-317
5. Hung RJ et al (2005) Perspectives on the molecular epidemiology of aerodigestive tract cancers. Mutat Res 592(1-2):102-118
6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860-867
7. Imhof A et al (2004) Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J 25(23):2092-2100
8. Kuschner WG et al (1996) Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 9(10):1989-1994
9. Matanic D et al (2003) Cytokines in patients with lung cancer. Scand J Immunol 57(2):173-178
10. Li N et al (2005) Overexpression of 5-lipoxygenase and cyclo-oxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib. Clin Cancer Res 11(5):2089-2096
11. Zhi H et al (2006) Significance of COX-2 expression in human esophageal squamous cell carcinoma. Carcinogenesis 27(6):1214-1221
12. Anto RJ et al (2002) Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 23(9):1511-1518
13. Corley DA et al (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124(1):47-56
14. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-179
15. Zhu YM et al (2004) Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 91(11):1970-1976
16. Koch AE et al (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258(5089):1798-1801
17. Garte S et al (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10(12):1239-1248
18. Hung RJ et al (2005) Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 97(8):567-576
19. Hashibe M et al (2006) Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 15(4):696-703
20. Wacholder S et al (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96(6):434-442
21. El-Omar EM et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398-402
22. Haukim N et al (2002) Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 3(6):313-330
23. Zienolddiny S et al (2004) Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109(3):353-356
24. Campa D et al (2005) Lack of association between polymorphisms in inflammatory genes and lung cancer risk. Cancer Epidemiol Biomarkers Prev 14(2):538-539
25. Rad R et al (2004) Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53(8):1082-1089
26. Campa D et al (2004) Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 25(2):229-235
27. Langsenlehner U et al (2006) The cyclooxygenase-2 (PTGS2) 8473T > C polymorphism is associated with breast cancer risk. Clin Cancer Res 12(4):1392-1394
28. Gammon MD et al (2004) Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study. Cancer Epidemiol Biomarkers Prev 13(1):34-39
29. Nabors LB et al (2001) HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61(5):2154-2161
30. Hull J et al (2001) Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 69(2):413-419
31. Lee WP et al (2005) The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 11(18):6431-6441
32. Taguchi A et al (2005) Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2487-2493
33. Savage SA et al (2006) Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 15(3):589-591